MoonLake Immunotherapeutics
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $477.9M | $298.5M | $334.5M | $350.7M | $306.7M | $271.6M | $180.4M | $375.7M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $570.0M | $396.6M | $421.7M | $411.2M | $455.5M | $506.3M | $474.3M | $512.3M |
| Property, Plant & Equipment | $487.0K | $532.0K | $577.0K | $622.0K | $667.0K | $711.0K | $722.0K | $581.4K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $573.9M | $400.4M | $424.4M | $414.3M | $460.1M | $511.3M | $477.9M | $518.2M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $45.4M | $46.1M | $45.5M | $48.4M | $27.4M | $24.0M | $22.5M | $20.1M |
| Long-Term Debt | $99.5M | $99.0M | $74.1M | $73.7M | $73.4M | $73.0M | $0 | — |
| Total Liabilities | $145.8M | $146.4M | $120.0M | $123.1M | $102.2M | $98.7M | $24.5M | $22.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-594.4M | $-532.6M | $-462.9M | $-400.5M | $-330.8M | $-275.5M | $-235.6M | $-190.0M |
| Total Stockholders' Equity | $428.2M | $254.0M | $304.5M | $288.9M | $353.7M | $407.5M | $446.8M | $488.2M |